Convergent Research Consortium for Immunologic Disease, The Catholic University of Korea, Seoul, Korea.
PLoS One. 2013 Aug 29;8(8):e72685. doi: 10.1371/journal.pone.0072685. eCollection 2013.
This study was performed to investigate whether ginseng has a protective effect in an experimental mouse model of cyclosporine-induced pancreatic injury.
Mice were treated with cyclosporine (30 mg/kg/day, subcutaneously) and Korean red ginseng extract (0.2 or 0.4 g/kg/day, oral gavage) for 4 weeks while on a 0.01% salt diet. The effect of ginseng on cyclosporine-induced pancreatic islet dysfunction was investigated by an intraperitoneal glucose tolerance test and measurements of serum insulin level, β cell area, macrophage infiltration, and apoptosis. Using an in vitro model, we further examined the effect of ginseng on a cyclosporine-treated insulin-secreting cell line. Oxidative stress was measured by the concentration of 8-hydroxy-2'-deoxyguanosine in serum, tissue sections, and culture media.
Four weeks of cyclosporine treatment increased blood glucose levels and decreased insulin levels, but cotreatment with ginseng ameliorated the cyclosporine-induced glucose intolerance and hyperglycemia. Pancreatic β cell area was also greater with ginseng cotreatment compared with cyclosporine monotherapy. The production of proinflammatory molecules, such as induced nitric oxide synthase and cytokines, and the level of apoptotic cell death also decreased in pancreatic β cell with ginseng treatment. Consistent with the in vivo results, the in vitro study showed that the addition of ginseng protected against cyclosporine-induced cytotoxicity, inflammation, and apoptotic cell death. These in vivo and in vitro changes were accompanied by decreases in the levels of 8-hydroxy-2'-deoxyguanosine in pancreatic β cell in tissue section, serum, and culture media during cotreatment of ginseng with cyclosporine.
The results of our in vivo and in vitro studies demonstrate that ginseng has a protective effect against cyclosporine-induced pancreatic β cell injury via reducing oxidative stress.
本研究旨在探讨人参是否对环孢素诱导的小鼠胰腺损伤具有保护作用。
将小鼠用环孢素(30mg/kg/天,皮下注射)和高丽红参提取物(0.2 或 0.4g/kg/天,口服灌胃)处理 4 周,同时给予 0.01%盐饮食。通过腹腔内葡萄糖耐量试验和测量血清胰岛素水平、β细胞面积、巨噬细胞浸润和细胞凋亡,研究人参对环孢素诱导的胰岛功能障碍的影响。在体外模型中,我们进一步研究了人参对环孢素处理的胰岛素分泌细胞系的作用。通过血清、组织切片和培养介质中 8-羟基-2'-脱氧鸟苷的浓度来测量氧化应激。
4 周的环孢素处理增加了血糖水平并降低了胰岛素水平,但与人参共同处理可改善环孢素诱导的葡萄糖不耐受和高血糖。与环孢素单药治疗相比,人参共同处理时胰腺β细胞面积也更大。与环孢素处理相比,促炎分子(如诱导型一氧化氮合酶和细胞因子)的产生和凋亡细胞死亡水平也降低了。与体内结果一致,体外研究表明,人参的添加可防止环孢素诱导的细胞毒性、炎症和凋亡细胞死亡。在与环孢素共同处理时,体内和体外的这些变化伴随着胰腺β细胞中 8-羟基-2'-脱氧鸟苷水平在组织切片、血清和培养介质中的降低。
我们的体内和体外研究结果表明,人参通过减少氧化应激对环孢素诱导的胰腺β细胞损伤具有保护作用。